-+ 0.00%
-+ 0.00%
-+ 0.00%

Jyong Biotech updates MCS-2 BPH/LUTS program; Phase III trials span 27 U.S. centers in 19 states

Reuters·03/27/2026 12:30:24

Please log in to view news